Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-12-12
2006-12-12
Morris, Patricia L. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07148357
ABSTRACT:
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinamides, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, as well as intermediate products for the production of the compounds are described. The compounds according to the invention can be used as or in the case of tumor or metastasis growth, psoriasis, Kaposi's sarcoma, restenosis, such as, e.g., stent-induced restenosis, endometriosis, Crohn's disease, Hodgkin's disease, leukemia; arthritis, such as rheumatoid arthritis, hemangioma, angiofibroma; eye diseases, such as diabetic retinopathy, neovascular glaucoma; renal diseases, such as glomerulonephritis, diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy; fibrotic diseases, such as cirrhosis of the liver, mesangial cell proliferative diseases, arteriosclerosis, injuries to nerve tissue, and inhibition of the reocclusion of vessels after balloon catheter treatment, in vascular prosthetics or after mechanical devices are used to keep vessels open, such as, e.g., stents, as immunosuppressive agents, as a support in scar-free healing, senile keratosis and contact dermatitis. The compounds according to the invention can also be used as VEGFR-3 inhibitors in the case of lymphangiogenesis.
REFERENCES:
patent: 2002/0147198 (2002-10-01), Chen et al.
Haberey Martin
Hess-Stumpp Holger
Huth Andreas
Ince Stuat
Kruger Martin
Morris Patricia L.
Schering AG
LandOfFree
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3712937